e human gene for producing alcohol dehydrogenase DH; EC 1.1.1.1) is polymorphic at ADH 2 and ADH 3 loci. rtII now, the study of this polymorphismrequired liver opsy or allele-specific radioactive probes. We have used rected mutagenesis by the polymerase chain reaction ICR) to amplify and analyze the genotype of ADH 2 and DH 3 loci. Thus, we coulddetermine easily and unambigusly the complete genotype at these two loci by using a icrosample of blood and restriction fragment length polyorphismafter DNA amplificationby PCR.
PCR
Whole blood (with citrate, EDTA, or heparin). We performed PCR with 3 zL of blood. The erythrocytes were lysed by adding 100 p.L of NaCl (37 mmol/L). The leukocytes were pelleted by centrifugation (1 mm, 10000 x g). The supernatant fluid was carefully removed and discarded. The pellet was suspended in 1. Blotted venous blood. We punched out 0.5-mm-diameter discs of filter paper onto which blood had been blotted. The discs were placed directly in the reaction mixture (100 p.L) and overlaid with 100 ,uL of mineral oil. Enzymatic amplification by PCR was then performed as described above.
Allele Detection by Restriction Enzyme Digestion
For allele detections, we precipitated the amplification mixture with ethanol. Samples were digested for 2 h with Mae ifi for detection of ADH, with Alu I for detection of ADH, and with Sap I for differentiation of ADH and ADH under the supplier's (Boehringer Mannheim, Mannheim, F.RG.) recommended conditions. Aliquots were run on 10% polyacrylamide gels, stained with ethidium bromide, and photographed on Polaroid Type 665 film.
Results and DiscussIon
Genot.,qie at the ADH2 locus. Three alleles are known for the ADH 2 locus: ADH, ADH, and ADH, coding for the /3k, /3, and /3 subunits, respectively. Therefore, there are six possible genotypes for this locus. We have devised a method for detection of each allele, based on restriction fragment length polymorphism (RFLP), i.e., on the absence or presence of a restriction site characteristic of each allele after PCR amplification of specific regions. With this method we can determine whether the allele is present in a (Figure 1) . This modification creates a Mae UI restriction site. The location of the primers for amplification of this region was chosen for the following reasons. First, 35 basepairs (bp) from this ADH characteristic Mae ifi site is another Mae III site, present in all ADH genes (Figure 1) . Including this second site in the amplified fragment provided an internal control for the digestion procedure (incomplete digestion of the amplified DNA fragment can lead to confusion between /3if3 and 131132 genotypes). Thus, including this internal control for digestion allows us to determine the genotype unambiguously. Moreover, taking into account the homology between the three loci-ADH 1, ADH 2, and ADH 3-we chose the primers in regions of ADH 1, ADH 2, and ADH 3 that differ, to avoid amplification of the other ADH genes. This specificity was controlled by the digestion of the amplified DNA with Kpn I, which has a site only in ADH 1, and with Pat I, which has a site only in ADH 3 (data not shown). Figure 2 shows the result of the ADH detection after digestion of the amplified region with Mae ifi.
Identification of the ADH allele. The ADH detection strategy is summarized in Figure 3 Figure 3) . The primer 352 contains a G/A mismatch. Thus, this PCR-directed mutagenesis creates the sequence AGCC for ADH and ADH and the sequence AGCT for ADH, which is the Alu I recognition site (see Figure 3) . Moreover, there are two other Alu I restriction sites in the amplified segment, which provide an internal control for the digestion procedure. Because one of these Alu sites is present only in the ADH 2 gene, the digestion with Alu I verifies that only the ADH 2 gene was amplified. Thus, the primer 321 contains two misatches, giving rise to the sequence AATATF, which is ognized by the enzyme Ssp I. Moreover, the location of two primers 321 and 351 was chosen to amplifr only the H 3 gene. This specificity was controlled by digestion of amplified DNA with Nla Ill, which has one site in ADH nd ADH 2, but none in ADH 3 (data not shown). In summary, we can now determine unambiguously and ry quickly the genotype at ADH 2 and ADH 3 loci. This thod presents improvements with good reliability. Parilarly, the use of an internal control for digestion avoids confusions from incomplete digestions. Second, this thod requires only a microsample of blood, either treated 
